QuickView for CACNB2, SH3 domain (biogroup)

1. Chemotherapeutic treatment of MCF7, ZR-75-1, HME-CC, and ME16C cell lines
2. Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
3. Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
4. Programming human pluripotent stem cells into adipocytes
5. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations

There were no matches for CACNB2, SH3 domain

There were no clinical trials for CACNB2, SH3 domain